{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:45:52Z","timestamp":1787791552154,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006401","name":"Charcot Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["1S34321N"],"award-info":[{"award-number":["1S34321N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.biopha.2025.117960","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T01:04:51Z","timestamp":1743037491000},"page":"117960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["EAAT3 modulation: A potential novel avenue towards remyelination in multiple sclerosis"],"prefix":"10.1016","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7725-8710","authenticated-orcid":false,"given":"Lieve","family":"van Veggel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8090-8489","authenticated-orcid":false,"given":"Melissa","family":"Schepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assia","family":"Tiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0008-9944","authenticated-orcid":false,"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Rombaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurrie","family":"Noordijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9765-4443","authenticated-orcid":false,"given":"Tim","family":"Vangansewinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Wolfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berra","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien","family":"Nouboers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6409-1544","authenticated-orcid":false,"given":"Pablo R.","family":"Moya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9291-4640","authenticated-orcid":false,"given":"David B.","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Dili\u00ebn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2308-406X","authenticated-orcid":false,"given":"Niels","family":"Hellings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2912-0578","authenticated-orcid":false,"given":"Tim","family":"Vanmierlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.117960_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00401-017-1741-7","article-title":"Myelin regulatory factor drives remyelination in multiple sclerosis","volume":"134","author":"Duncan","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2025.117960_bib2","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3390\/cells8101236","article-title":"From OPC to oligodendrocyte: an epigenetic journey","volume":"8","author":"Tiane","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.117960_bib3","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1007\/s00018-021-03802-0","article-title":"Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders","volume":"78","author":"Spaas","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2025.117960_bib4","doi-asserted-by":"crossref","first-page":"14973","DOI":"10.1523\/JNEUROSCI.1156-14.2014","article-title":"Migration of oligodendrocyte progenitor cells is controlled by transforming growth factor \u03b2 family proteins during corticogenesis","volume":"34","author":"Choe","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.117960_bib5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41593-020-0637-3","article-title":"Motor learning promotes remyelination via new and surviving oligodendrocytes","volume":"23","author":"Bacmeister","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2025.117960_bib6","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.3892\/etm.2017.4410","article-title":"Multiple sclerosis: pathology, diagnosis and treatments","volume":"13","author":"Huang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2025.117960_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10072-014-1925-z","article-title":"Economic impact of multiple sclerosis in Italy: focus on rehabilitation costs","volume":"36","author":"Ponzio","year":"2015","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.biopha.2025.117960_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13293-019-0243-9","article-title":"Polypharmacy in patients with multiple sclerosis: a gender-specific analysis","volume":"10","author":"Frahm","year":"2019","journal-title":"Biol. Sex. Differ."},{"key":"10.1016\/j.biopha.2025.117960_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","article-title":"Secondary progressive multiple sclerosis: new insights","volume":"97","author":"Cree","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.117960_bib10","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1093\/brain\/awac307","article-title":"Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?","volume":"145","author":"Tepav\u010devi\u0107","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2025.117960_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00401-023-02596-8","article-title":"From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions","volume":"146","author":"Tiane","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2025.117960_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2022.12.020","article-title":"Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis","volume":"109","author":"Schepers","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.biopha.2025.117960_bib13","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/cdd.2008.70","article-title":"Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease","volume":"15","author":"Butts","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2025.117960_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/(SICI)1098-1136(199804)22:4<371::AID-GLIA6>3.0.CO;2-6","article-title":"Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress","volume":"22","author":"Juurlink","year":"1998","journal-title":"Glia"},{"key":"10.1016\/j.biopha.2025.117960_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.advms.2017.05.005","article-title":"Endogenous non-enzymatic antioxidants in the human body","volume":"63","author":"Miro\u0144czuk-Chodakowska","year":"2018","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.biopha.2025.117960_bib16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1289\/ehp.1408418","article-title":"Mitochondria, energetics, epigenetics, and cellular responses to stress","volume":"122","author":"Shaughnessy","year":"2015","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.biopha.2025.117960_bib17","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1161\/STROKEAHA.113.002813","article-title":"Oxidative stress interferes with white matter renewal after prolonged cerebral hypoperfusion in mice","volume":"44","author":"Miyamoto","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.biopha.2025.117960_bib18","first-page":"1","article-title":"Selective neuronal vulnerability to oxidative stress in the brain","volume":"2","author":"Wang","year":"2010","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.biopha.2025.117960_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2025.117960_bib20","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.freeradbiomed.2015.09.023","article-title":"Glutathione - linking cell proliferation to oxidative stress","volume":"89","author":"Diaz-Vivancos","year":"2015","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.biopha.2025.117960_bib21","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00702-003-0049-z","article-title":"Role of neuronal glutamate transporter in the cysteine uptake and intracellular glutathione levels in cultured cortical neurons","volume":"110","author":"Himi","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.biopha.2025.117960_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuint.2016.05.007","article-title":"The importance of the excitatory amino acid transporter 3 (EAAT3)","volume":"98","author":"Bj\u00f8rn-Yoshimoto","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2025.117960_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166324","article-title":"Myelin-associated glycoprotein activation triggers glutamate uptake by oligodendrocytes in vitro and contributes to ameliorate glutamate-mediated toxicity in vivo","volume":"1868","author":"Vivinetto","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2025.117960_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1469-7580.2007.00733.x","article-title":"Excitotoxic damage to white matter","volume":"210","author":"Matute","year":"2007","journal-title":"J. Anat."},{"key":"10.1016\/j.biopha.2025.117960_bib25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/01.WNL.0000090564.88719.37","article-title":"Glutamate uptake by oligodendrocytes: implications for excitotoxicity in multiple sclerosis","volume":"61","author":"Pitt","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2025.117960_bib26","doi-asserted-by":"crossref","first-page":"8518","DOI":"10.1038\/ncomms9518","article-title":"Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors","volume":"6","author":"Gautier","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117960_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.abf5814","article-title":"Cryo-EM structures of excitatory amino acid transporter 3 visualize coupled substrate, sodium, and proton binding and transport","volume":"7","author":"Qiu","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2025.117960_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41467-023-38120-5","article-title":"Symport and antiport mechanisms of human glutamate transporters","volume":"14","author":"Qiu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117960_bib29","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1021\/acschemneuro.9b00447","article-title":"Identification and structure-activity relationship study of imidazo[1,2- a]pyridine-3-amines as first selective inhibitors of excitatory amino acid transporter subtype 3 (EAAT3)","volume":"10","author":"Wu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2025.117960_bib30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","article-title":"Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis","volume":"47","author":"Praet","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2025.117960_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10735-019-09824-0","article-title":"Oligoprotective effect of metformin through the AMPK-dependent on restoration of mitochondrial hemostasis in the cuprizone-induced multiple sclerosis model","volume":"50","author":"Largani","year":"2019","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.biopha.2025.117960_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mito.2009.12.141","article-title":"Oligodendroglial differentiation induces mitochondrial genes and inhibition of mitochondrial function represses oligodendroglial differentiation","volume":"10","author":"Schoenfeld","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biopha.2025.117960_bib33","first-page":"1","article-title":"EAAT3 impedes oligodendrocyte remyelination in chronic cerebral hypoperfusion-induced white matter injury","volume":"30","author":"Zhang","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2025.117960_bib34","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41592-023-01863-6","article-title":"Glutamate indicators with improved activation kinetics and localization for imaging synaptic transmission","volume":"20","author":"Aggarwal","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biopha.2025.117960_bib35","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1093\/brain\/awac207","article-title":"Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy","volume":"145","author":"Cordano","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2025.117960_bib36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/bp990004b","article-title":"Proteomics: theoretical and experimental considerations","volume":"15","author":"Hatzimanikatis","year":"1999","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biopha.2025.117960_bib37","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5607\/en21013","article-title":"Adenovirus-induced reactive astrogliosis exacerbates the pathology of parkinson\u2019s disease","volume":"30","author":"An","year":"2021","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.biopha.2025.117960_bib38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nbd.2005.06.017","article-title":"Increased expression and function of glutamate transporters in multiple sclerosis","volume":"21","author":"Vallejo-Illarramendi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2025.117960_bib39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11064-018-02708-x","article-title":"Glutamate transporters: expression and function in oligodendrocytes","volume":"45","author":"Su\u00e1rez-Pozos","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2025.117960_bib40","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41586-022-05213-y","article-title":"Brain-restricted mTOR inhibition with binary pharmacology","volume":"609","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117960_bib41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.117960_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbrc.2012.03.109","article-title":"Regulation of the glutamate transporter EAAT3 by mammalian target of rapamycin mTOR","volume":"421","author":"Almilaji","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2025.117960_bib43","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301557RR","article-title":"The sphingosine-1-phosphate receptor 1 modulator ponesimod repairs cuprizone-induced demyelinationand induces oligodendrocyte differentiation","volume":"38","author":"Willems","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2025.117960_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-0716-0892-0_6","article-title":"Expression screening of human integral membrane proteins using BacMam","volume":"2199","author":"Mahajan","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2025.117960_bib45","article-title":"High-throughput expression and purification of human solute carriers for structural and biochemical studies","author":"D\u00fcrr","year":"2023","journal-title":"JoVE"},{"key":"10.1016\/j.biopha.2025.117960_bib46","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/acschemneuro.3c00731","article-title":"Still in Search for an EAAT activator: GT949 does not activate EAAT2, nor EAAT3 in impedance and radioligand uptake assays","volume":"15","author":"van Veggel","year":"2024","journal-title":"ACS Chem. Neurosci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:59:18Z","timestamp":1781823558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225001544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":46,"alternative-id":["S0753332225001544"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117960","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EAAT3 modulation: A potential novel avenue towards remyelination in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117960"}}